Business Overview
Following the success of efforts to develop manufacturing technology for MPC polymer containing phospholipid polar groups,
NOF moved to create an operational structure for the full-scale development of its Life Science Products Business.
This precipitated active moves into new markets for products with MPC polymer applications.
There are a number of fields where MPC polymer can demonstrate its groundbreaking advanced biocompatible functions.
Currently, MPC polymer, found in biocompatible-related products supplied by NOF (the LIPIDURE® Series),
is used in a wide range of applications, including cleaning and storage solutions for contact lenses,
cosmetic ingredients used in haircare and skincare products, and textile processing agents that result in fabrics
that are kinder on the skin.
The Life Science Products Business' range of oxidation stress markers for genes, lipids and sugars are also used
as diagnostic and research-use agents in research into ageing and lifestyle-related diseases.
Going forward, centered on its unique portfolio of key technologies,
the Life Science Products Business will play its part in enhancing the quality of life.
Lipidure
Biolipidure
Blocking reagents & Stabilizer
For more details, please visit NOF CORPORATION web site.
http://www.nof.co.jp/english/business/life/index.html
|
What's New
DDS
2011/11/7
NOF exhibits DDS products at CPhI India
- Date: 30 November - 2 December 2011
-Location:Bombay Exhibition Centre
- NOF Booth: #N19
URL:http://www.cphi-india.com
2011/10/26
DDS Excipients Catalog ver.13 is Now Available
NOF is pleased to announce our new Catalog for DDS Excipients.
Please do not hesitate to ask us for obtaining the Catalog, together with your contact information.
NOF CORPORATION
DDS Development Division
E-mail : ddsinfo@nof.co.jp
NOF exhibits cutting-edge excipients and tech. for DDS at CPhI Frankfurt
2011/05/15
NOF attends the TIDE 2011 at Boson, MA (May 22-25)
2011/03/17
ICBS2011 has been cancelled due to earthquake in Japan
Due to the major earthquake in northern Japan on Mar. 11, International Conference on Biomaterials Science 2011 in Tsukuba has been cancelled.
As one of supporters of this event, we receive the news with sincere regret and express our heartfelt sympathy to earthquake victims.
We are praying for speedy recovery of disaster area.
URL
2011/02/17
(Update date) NOF co-hosts International Conference on Biomaterials Science 2011 in Tsukuba, Japan (Mar.15-18)
2011/02/04
NOF exhibits cutting-edge excipients & tech at ASIA TIDES in Tokyo (Mar.2-4)
2010/09/28
NOF release New Activated PEG
2010/09/21
NOF's Activated PEG Used in an U.S. FDA Approved PEGylated Drug
2010/09/07
NOF exhibits cutting edge excipients & tech. for DDS in CPhI Worldwide Paris, France (Oct. 5- 7)
2010/07/26
Program for Liposome Conference in Vancouver, Aug 4-8, 2010
2010/07/08
NOF presents at Liposome Conference in Vancouver, Aug 4-8, 2010
2010/06/30 NOF release New Activated PEG
2010/05/21 NOF AMERICA CORPORATION opened a new office in California
On May 7, NOF AMERICA CORPORATION, a wholly owned subsidiary of NOF,
opened a new office in California to further enhance its sales
activities in the North American market
Post Address: 2102 Business Center Drive, Suite 130 Irvine, CA 92612, USA
2010/03/11 NOF partners with ENZON on PEG derivatives
PDF
2010/01/07 NOF signs Exclusive Licensing Agreement on Novel Carrier for Gene Delivery
PDF
|
